Vishal Yadav, CEO and founder, FDI India lists the reasons why he believes the Indian pharma sector is a “hot-bed” for investments, reflected as increasing FDI inflows, in an interaction with Viveka Roychowdhury.
In October 2020, the healthcare industry reported 86 deals worth $25.5 billion as compared to the last 12-month average (October 2019 to September 2020) of 78 deals worth $13 billion.
A report by the UK Bio Industry Association (BIA) and Informa Pharmaceutical Intelligence recorded that the UK biotech sector raised £2.2bn from investors in 2018.....